Home / Products / Pharmacopoeial impurities / Ixazomib Impurity N1

Ixazomib Impurity N1

CAS 1201903-02-7 Cat. no. RA-I059024 On synthesis

A pharmacopoeial impurity reference standard for this drug substance, characterised by HPLC, mass spectrometry and 1H NMR, and released with a lot-specific certificate of analysis.

Molecular formulaC24H33BCl2N2O4
Molecular weight495.26 g/mol
Available packsOn request
DocumentationCOA · SDS · spec sheet
Purity>90%
Storage2℃ ~ 8℃

No price is published: pack size, documents and shipping are confirmed in one quotation.

Chemical structure of Ixazomib Impurity N1, CAS 1201903-02-7

What this record covers

Ixazomib Impurity N1 (CAS 1201903-02-7) is supplied as a pure organic reference material under ISO 17034:2016 (ANAB, AR-2832). Each lot is weighed, dispensed and released against a specification that includes identity by mass spectrometry and 1H NMR, and purity by HPLC.

Typical use

Related-substance method development and validation, identification of impurity peaks in this drug substance drug substance, system suitability, and quantitative calibration where a defined reference is required.

Shipping and storage

Shipped worldwide with the SDS and, where applicable, a non-hazardous declaration. Cold-chain and dry ice are used when the material requires it; the storage condition and retest date are stated on the lot certificate rather than assumed from the catalogue.

Identifiers: catalogue RA-I059024 · CAS 1201903-02-7 · formula C24H33BCl2N2O4 · MW 495.26. If you need a different pack size or a co-lot certificate, ask — both are routine.

Other standards for this drug substance